Bevacizumab: Difference between revisions
David Canner (talk | contribs) New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="Rivastigmine/Riv/1" align="right" caption="Rivastigmine, also known as Exelon"/> ===Better Known as: Exelon=== * Marke... |
David Canner (talk | contribs) No edit summary |
||
| Line 41: | Line 41: | ||
! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ||
! [[Bevacizumab]] | ! [[Bevacizumab]] | ||
|- | |||
! [[Pharmaceutical_Drugs#Clearance_.28Cl.29|Clearance]] (L/h) | |||
! .098 | |||
|- | |- | ||
! Dosage (mg) | ! Dosage (mg) | ||